Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Yung Yuen, Tom Wai‐Hin Chung et al.|The Lancet|2020Cited by 1.6k
Emerging Infections Due to Shewanella spp.: A Case Series of 128 Cases Over 10 YearsWincy Wing‐Sze Ng, Siddharth Sridhar, Hoi‐Ping Shum et al.|Frontiers in Medicine|2022Cited by 40